Global AI Diagnostics Supply, Demand and Key Producers, 2024-2030

Global AI Diagnostics Supply, Demand and Key Producers, 2024-2030

Page: 135

Published Date: 17 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global AI Diagnostics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

As a subfield in artificial intelligence, diagnosis is concerned with the development of algorithms and techniques that are able to determine whether the behaviour of a system is correct.

This report studies the global AI Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for AI Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global AI Diagnostics total market, 2019-2030, (USD Million)
Global AI Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: AI Diagnostics total market, key domestic companies and share, (USD Million)
Global AI Diagnostics revenue by player and market share 2019-2024, (USD Million)
Global AI Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)
Global AI Diagnostics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global AI Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Oxitone Medical Ltd, MC10, Inc, Medtronic, UE LifeSciences, Vital Connect, Biomeme, MidMark Corp, Bio SB and Cerora, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global AI Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global AI Diagnostics Market, Segmentation by Type
Hardware
Software
Service

Global AI Diagnostics Market, Segmentation by Application
Hospitals
Research Laboratories
Contract Research Organizations
Others

Companies Profiled:
Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche

Key Questions Answered
1. How big is the global AI Diagnostics market?
2. What is the demand of the global AI Diagnostics market?
3. What is the year over year growth of the global AI Diagnostics market?
4. What is the total value of the global AI Diagnostics market?
5. Who are the major players in the global AI Diagnostics market?
btl

Table of Contents

1 Supply Summary
1.1 AI Diagnostics Introduction
1.2 World AI Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
1.3 World AI Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World AI Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States AI Diagnostics Market Size (2019-2030)
1.3.3 China AI Diagnostics Market Size (2019-2030)
1.3.4 Europe AI Diagnostics Market Size (2019-2030)
1.3.5 Japan AI Diagnostics Market Size (2019-2030)
1.3.6 South Korea AI Diagnostics Market Size (2019-2030)
1.3.7 ASEAN AI Diagnostics Market Size (2019-2030)
1.3.8 India AI Diagnostics Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI Diagnostics Major Market Trends

2 Demand Summary
2.1 World AI Diagnostics Consumption Value (2019-2030)
2.2 World AI Diagnostics Consumption Value by Region
2.2.1 World AI Diagnostics Consumption Value by Region (2019-2024)
2.2.2 World AI Diagnostics Consumption Value Forecast by Region (2025-2030)
2.3 United States AI Diagnostics Consumption Value (2019-2030)
2.4 China AI Diagnostics Consumption Value (2019-2030)
2.5 Europe AI Diagnostics Consumption Value (2019-2030)
2.6 Japan AI Diagnostics Consumption Value (2019-2030)
2.7 South Korea AI Diagnostics Consumption Value (2019-2030)
2.8 ASEAN AI Diagnostics Consumption Value (2019-2030)
2.9 India AI Diagnostics Consumption Value (2019-2030)

3 World AI Diagnostics Companies Competitive Analysis
3.1 World AI Diagnostics Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Diagnostics in 2023
3.2.3 Global Concentration Ratios (CR8) for AI Diagnostics in 2023
3.3 AI Diagnostics Company Evaluation Quadrant
3.4 AI Diagnostics Market: Overall Company Footprint Analysis
3.4.1 AI Diagnostics Market: Region Footprint
3.4.2 AI Diagnostics Market: Company Product Type Footprint
3.4.3 AI Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: AI Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Diagnostics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: AI Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: AI Diagnostics Consumption Value Comparison
4.2.1 United States VS China: AI Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: AI Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based AI Diagnostics Companies and Market Share, 2019-2024
4.3.1 United States Based AI Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Diagnostics Revenue, (2019-2024)
4.4 China Based Companies AI Diagnostics Revenue and Market Share, 2019-2024
4.4.1 China Based AI Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Diagnostics Revenue, (2019-2024)
4.5 Rest of World Based AI Diagnostics Companies and Market Share, 2019-2024
4.5.1 Rest of World Based AI Diagnostics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI Diagnostics Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World AI Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Service
5.3 Market Segment by Type
5.3.1 World AI Diagnostics Market Size by Type (2019-2024)
5.3.2 World AI Diagnostics Market Size by Type (2025-2030)
5.3.3 World AI Diagnostics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World AI Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Research Laboratories
6.2.3 Contract Research Organizations
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World AI Diagnostics Market Size by Application (2019-2024)
6.3.2 World AI Diagnostics Market Size by Application (2025-2030)
6.3.3 World AI Diagnostics Market Size by Application (2019-2030)

7 Company Profiles
7.1 Oxitone Medical Ltd
7.1.1 Oxitone Medical Ltd Details
7.1.2 Oxitone Medical Ltd Major Business
7.1.3 Oxitone Medical Ltd AI Diagnostics Product and Services
7.1.4 Oxitone Medical Ltd AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Oxitone Medical Ltd Recent Developments/Updates
7.1.6 Oxitone Medical Ltd Competitive Strengths & Weaknesses
7.2 MC10, Inc
7.2.1 MC10, Inc Details
7.2.2 MC10, Inc Major Business
7.2.3 MC10, Inc AI Diagnostics Product and Services
7.2.4 MC10, Inc AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 MC10, Inc Recent Developments/Updates
7.2.6 MC10, Inc Competitive Strengths & Weaknesses
7.3 Medtronic
7.3.1 Medtronic Details
7.3.2 Medtronic Major Business
7.3.3 Medtronic AI Diagnostics Product and Services
7.3.4 Medtronic AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Medtronic Recent Developments/Updates
7.3.6 Medtronic Competitive Strengths & Weaknesses
7.4 UE LifeSciences
7.4.1 UE LifeSciences Details
7.4.2 UE LifeSciences Major Business
7.4.3 UE LifeSciences AI Diagnostics Product and Services
7.4.4 UE LifeSciences AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 UE LifeSciences Recent Developments/Updates
7.4.6 UE LifeSciences Competitive Strengths & Weaknesses
7.5 Vital Connect
7.5.1 Vital Connect Details
7.5.2 Vital Connect Major Business
7.5.3 Vital Connect AI Diagnostics Product and Services
7.5.4 Vital Connect AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Vital Connect Recent Developments/Updates
7.5.6 Vital Connect Competitive Strengths & Weaknesses
7.6 Biomeme
7.6.1 Biomeme Details
7.6.2 Biomeme Major Business
7.6.3 Biomeme AI Diagnostics Product and Services
7.6.4 Biomeme AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Biomeme Recent Developments/Updates
7.6.6 Biomeme Competitive Strengths & Weaknesses
7.7 MidMark Corp
7.7.1 MidMark Corp Details
7.7.2 MidMark Corp Major Business
7.7.3 MidMark Corp AI Diagnostics Product and Services
7.7.4 MidMark Corp AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 MidMark Corp Recent Developments/Updates
7.7.6 MidMark Corp Competitive Strengths & Weaknesses
7.8 Bio SB
7.8.1 Bio SB Details
7.8.2 Bio SB Major Business
7.8.3 Bio SB AI Diagnostics Product and Services
7.8.4 Bio SB AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Bio SB Recent Developments/Updates
7.8.6 Bio SB Competitive Strengths & Weaknesses
7.9 Cerora
7.9.1 Cerora Details
7.9.2 Cerora Major Business
7.9.3 Cerora AI Diagnostics Product and Services
7.9.4 Cerora AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Cerora Recent Developments/Updates
7.9.6 Cerora Competitive Strengths & Weaknesses
7.10 CellScope
7.10.1 CellScope Details
7.10.2 CellScope Major Business
7.10.3 CellScope AI Diagnostics Product and Services
7.10.4 CellScope AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 CellScope Recent Developments/Updates
7.10.6 CellScope Competitive Strengths & Weaknesses
7.11 Digital Diagnostics
7.11.1 Digital Diagnostics Details
7.11.2 Digital Diagnostics Major Business
7.11.3 Digital Diagnostics AI Diagnostics Product and Services
7.11.4 Digital Diagnostics AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Digital Diagnostics Recent Developments/Updates
7.11.6 Digital Diagnostics Competitive Strengths & Weaknesses
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Details
7.12.2 Siemens Healthineers Major Business
7.12.3 Siemens Healthineers AI Diagnostics Product and Services
7.12.4 Siemens Healthineers AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Siemens Healthineers Recent Developments/Updates
7.12.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.13 Nanox
7.13.1 Nanox Details
7.13.2 Nanox Major Business
7.13.3 Nanox AI Diagnostics Product and Services
7.13.4 Nanox AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Nanox Recent Developments/Updates
7.13.6 Nanox Competitive Strengths & Weaknesses
7.14 Roche
7.14.1 Roche Details
7.14.2 Roche Major Business
7.14.3 Roche AI Diagnostics Product and Services
7.14.4 Roche AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Roche Recent Developments/Updates
7.14.6 Roche Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 AI Diagnostics Industry Chain
8.2 AI Diagnostics Upstream Analysis
8.3 AI Diagnostics Midstream Analysis
8.4 AI Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World AI Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World AI Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World AI Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World AI Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World AI Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World AI Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World AI Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World AI Diagnostics Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key AI Diagnostics Players in 2023
Table 12. World AI Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global AI Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key AI Diagnostics Player
Table 15. AI Diagnostics Market: Company Product Type Footprint
Table 16. AI Diagnostics Market: Company Product Application Footprint
Table 17. AI Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China AI Diagnostics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China AI Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based AI Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Diagnostics Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies AI Diagnostics Revenue Market Share (2019-2024)
Table 23. China Based AI Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Diagnostics Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies AI Diagnostics Revenue Market Share (2019-2024)
Table 26. Rest of World Based AI Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI Diagnostics Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies AI Diagnostics Revenue Market Share (2019-2024)
Table 29. World AI Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World AI Diagnostics Market Size by Type (2019-2024) & (USD Million)
Table 31. World AI Diagnostics Market Size by Type (2025-2030) & (USD Million)
Table 32. World AI Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World AI Diagnostics Market Size by Application (2019-2024) & (USD Million)
Table 34. World AI Diagnostics Market Size by Application (2025-2030) & (USD Million)
Table 35. Oxitone Medical Ltd Basic Information, Area Served and Competitors
Table 36. Oxitone Medical Ltd Major Business
Table 37. Oxitone Medical Ltd AI Diagnostics Product and Services
Table 38. Oxitone Medical Ltd AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Oxitone Medical Ltd Recent Developments/Updates
Table 40. Oxitone Medical Ltd Competitive Strengths & Weaknesses
Table 41. MC10, Inc Basic Information, Area Served and Competitors
Table 42. MC10, Inc Major Business
Table 43. MC10, Inc AI Diagnostics Product and Services
Table 44. MC10, Inc AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. MC10, Inc Recent Developments/Updates
Table 46. MC10, Inc Competitive Strengths & Weaknesses
Table 47. Medtronic Basic Information, Area Served and Competitors
Table 48. Medtronic Major Business
Table 49. Medtronic AI Diagnostics Product and Services
Table 50. Medtronic AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Medtronic Recent Developments/Updates
Table 52. Medtronic Competitive Strengths & Weaknesses
Table 53. UE LifeSciences Basic Information, Area Served and Competitors
Table 54. UE LifeSciences Major Business
Table 55. UE LifeSciences AI Diagnostics Product and Services
Table 56. UE LifeSciences AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. UE LifeSciences Recent Developments/Updates
Table 58. UE LifeSciences Competitive Strengths & Weaknesses
Table 59. Vital Connect Basic Information, Area Served and Competitors
Table 60. Vital Connect Major Business
Table 61. Vital Connect AI Diagnostics Product and Services
Table 62. Vital Connect AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Vital Connect Recent Developments/Updates
Table 64. Vital Connect Competitive Strengths & Weaknesses
Table 65. Biomeme Basic Information, Area Served and Competitors
Table 66. Biomeme Major Business
Table 67. Biomeme AI Diagnostics Product and Services
Table 68. Biomeme AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Biomeme Recent Developments/Updates
Table 70. Biomeme Competitive Strengths & Weaknesses
Table 71. MidMark Corp Basic Information, Area Served and Competitors
Table 72. MidMark Corp Major Business
Table 73. MidMark Corp AI Diagnostics Product and Services
Table 74. MidMark Corp AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. MidMark Corp Recent Developments/Updates
Table 76. MidMark Corp Competitive Strengths & Weaknesses
Table 77. Bio SB Basic Information, Area Served and Competitors
Table 78. Bio SB Major Business
Table 79. Bio SB AI Diagnostics Product and Services
Table 80. Bio SB AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Bio SB Recent Developments/Updates
Table 82. Bio SB Competitive Strengths & Weaknesses
Table 83. Cerora Basic Information, Area Served and Competitors
Table 84. Cerora Major Business
Table 85. Cerora AI Diagnostics Product and Services
Table 86. Cerora AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Cerora Recent Developments/Updates
Table 88. Cerora Competitive Strengths & Weaknesses
Table 89. CellScope Basic Information, Area Served and Competitors
Table 90. CellScope Major Business
Table 91. CellScope AI Diagnostics Product and Services
Table 92. CellScope AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. CellScope Recent Developments/Updates
Table 94. CellScope Competitive Strengths & Weaknesses
Table 95. Digital Diagnostics Basic Information, Area Served and Competitors
Table 96. Digital Diagnostics Major Business
Table 97. Digital Diagnostics AI Diagnostics Product and Services
Table 98. Digital Diagnostics AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Digital Diagnostics Recent Developments/Updates
Table 100. Digital Diagnostics Competitive Strengths & Weaknesses
Table 101. Siemens Healthineers Basic Information, Area Served and Competitors
Table 102. Siemens Healthineers Major Business
Table 103. Siemens Healthineers AI Diagnostics Product and Services
Table 104. Siemens Healthineers AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Siemens Healthineers Recent Developments/Updates
Table 106. Siemens Healthineers Competitive Strengths & Weaknesses
Table 107. Nanox Basic Information, Area Served and Competitors
Table 108. Nanox Major Business
Table 109. Nanox AI Diagnostics Product and Services
Table 110. Nanox AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Nanox Recent Developments/Updates
Table 112. Roche Basic Information, Area Served and Competitors
Table 113. Roche Major Business
Table 114. Roche AI Diagnostics Product and Services
Table 115. Roche AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of AI Diagnostics Upstream (Raw Materials)
Table 117. AI Diagnostics Typical Customers
List of Figure
Figure 1. AI Diagnostics Picture
Figure 2. World AI Diagnostics Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World AI Diagnostics Total Market Size (2019-2030) & (USD Million)
Figure 4. World AI Diagnostics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World AI Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 13. AI Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 16. World AI Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. United States AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 18. China AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. India AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of AI Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Diagnostics Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Diagnostics Markets in 2023
Figure 27. United States VS China: AI Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: AI Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World AI Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World AI Diagnostics Market Size Market Share by Type in 2023
Figure 31. Hardware
Figure 32. Software
Figure 33. Service
Figure 34. World AI Diagnostics Market Size Market Share by Type (2019-2030)
Figure 35. World AI Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World AI Diagnostics Market Size Market Share by Application in 2023
Figure 37. Hospitals
Figure 38. Research Laboratories
Figure 39. Contract Research Organizations
Figure 40. Others
Figure 41. AI Diagnostics Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global AI Diagnostics Supply, Demand and Key Producers, 2024-2030

Global AI Diagnostics Supply, Demand and Key Producers, 2024-2030

Page: 135

Published Date: 17 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global AI Diagnostics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

As a subfield in artificial intelligence, diagnosis is concerned with the development of algorithms and techniques that are able to determine whether the behaviour of a system is correct.

This report studies the global AI Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for AI Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global AI Diagnostics total market, 2019-2030, (USD Million)
Global AI Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: AI Diagnostics total market, key domestic companies and share, (USD Million)
Global AI Diagnostics revenue by player and market share 2019-2024, (USD Million)
Global AI Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)
Global AI Diagnostics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global AI Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Oxitone Medical Ltd, MC10, Inc, Medtronic, UE LifeSciences, Vital Connect, Biomeme, MidMark Corp, Bio SB and Cerora, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global AI Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global AI Diagnostics Market, Segmentation by Type
Hardware
Software
Service

Global AI Diagnostics Market, Segmentation by Application
Hospitals
Research Laboratories
Contract Research Organizations
Others

Companies Profiled:
Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche

Key Questions Answered
1. How big is the global AI Diagnostics market?
2. What is the demand of the global AI Diagnostics market?
3. What is the year over year growth of the global AI Diagnostics market?
4. What is the total value of the global AI Diagnostics market?
5. Who are the major players in the global AI Diagnostics market?
btl

Table of Contents

1 Supply Summary
1.1 AI Diagnostics Introduction
1.2 World AI Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
1.3 World AI Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World AI Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States AI Diagnostics Market Size (2019-2030)
1.3.3 China AI Diagnostics Market Size (2019-2030)
1.3.4 Europe AI Diagnostics Market Size (2019-2030)
1.3.5 Japan AI Diagnostics Market Size (2019-2030)
1.3.6 South Korea AI Diagnostics Market Size (2019-2030)
1.3.7 ASEAN AI Diagnostics Market Size (2019-2030)
1.3.8 India AI Diagnostics Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI Diagnostics Major Market Trends

2 Demand Summary
2.1 World AI Diagnostics Consumption Value (2019-2030)
2.2 World AI Diagnostics Consumption Value by Region
2.2.1 World AI Diagnostics Consumption Value by Region (2019-2024)
2.2.2 World AI Diagnostics Consumption Value Forecast by Region (2025-2030)
2.3 United States AI Diagnostics Consumption Value (2019-2030)
2.4 China AI Diagnostics Consumption Value (2019-2030)
2.5 Europe AI Diagnostics Consumption Value (2019-2030)
2.6 Japan AI Diagnostics Consumption Value (2019-2030)
2.7 South Korea AI Diagnostics Consumption Value (2019-2030)
2.8 ASEAN AI Diagnostics Consumption Value (2019-2030)
2.9 India AI Diagnostics Consumption Value (2019-2030)

3 World AI Diagnostics Companies Competitive Analysis
3.1 World AI Diagnostics Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Diagnostics in 2023
3.2.3 Global Concentration Ratios (CR8) for AI Diagnostics in 2023
3.3 AI Diagnostics Company Evaluation Quadrant
3.4 AI Diagnostics Market: Overall Company Footprint Analysis
3.4.1 AI Diagnostics Market: Region Footprint
3.4.2 AI Diagnostics Market: Company Product Type Footprint
3.4.3 AI Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: AI Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Diagnostics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: AI Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: AI Diagnostics Consumption Value Comparison
4.2.1 United States VS China: AI Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: AI Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based AI Diagnostics Companies and Market Share, 2019-2024
4.3.1 United States Based AI Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Diagnostics Revenue, (2019-2024)
4.4 China Based Companies AI Diagnostics Revenue and Market Share, 2019-2024
4.4.1 China Based AI Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Diagnostics Revenue, (2019-2024)
4.5 Rest of World Based AI Diagnostics Companies and Market Share, 2019-2024
4.5.1 Rest of World Based AI Diagnostics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI Diagnostics Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World AI Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Service
5.3 Market Segment by Type
5.3.1 World AI Diagnostics Market Size by Type (2019-2024)
5.3.2 World AI Diagnostics Market Size by Type (2025-2030)
5.3.3 World AI Diagnostics Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World AI Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Research Laboratories
6.2.3 Contract Research Organizations
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World AI Diagnostics Market Size by Application (2019-2024)
6.3.2 World AI Diagnostics Market Size by Application (2025-2030)
6.3.3 World AI Diagnostics Market Size by Application (2019-2030)

7 Company Profiles
7.1 Oxitone Medical Ltd
7.1.1 Oxitone Medical Ltd Details
7.1.2 Oxitone Medical Ltd Major Business
7.1.3 Oxitone Medical Ltd AI Diagnostics Product and Services
7.1.4 Oxitone Medical Ltd AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Oxitone Medical Ltd Recent Developments/Updates
7.1.6 Oxitone Medical Ltd Competitive Strengths & Weaknesses
7.2 MC10, Inc
7.2.1 MC10, Inc Details
7.2.2 MC10, Inc Major Business
7.2.3 MC10, Inc AI Diagnostics Product and Services
7.2.4 MC10, Inc AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 MC10, Inc Recent Developments/Updates
7.2.6 MC10, Inc Competitive Strengths & Weaknesses
7.3 Medtronic
7.3.1 Medtronic Details
7.3.2 Medtronic Major Business
7.3.3 Medtronic AI Diagnostics Product and Services
7.3.4 Medtronic AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Medtronic Recent Developments/Updates
7.3.6 Medtronic Competitive Strengths & Weaknesses
7.4 UE LifeSciences
7.4.1 UE LifeSciences Details
7.4.2 UE LifeSciences Major Business
7.4.3 UE LifeSciences AI Diagnostics Product and Services
7.4.4 UE LifeSciences AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 UE LifeSciences Recent Developments/Updates
7.4.6 UE LifeSciences Competitive Strengths & Weaknesses
7.5 Vital Connect
7.5.1 Vital Connect Details
7.5.2 Vital Connect Major Business
7.5.3 Vital Connect AI Diagnostics Product and Services
7.5.4 Vital Connect AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Vital Connect Recent Developments/Updates
7.5.6 Vital Connect Competitive Strengths & Weaknesses
7.6 Biomeme
7.6.1 Biomeme Details
7.6.2 Biomeme Major Business
7.6.3 Biomeme AI Diagnostics Product and Services
7.6.4 Biomeme AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Biomeme Recent Developments/Updates
7.6.6 Biomeme Competitive Strengths & Weaknesses
7.7 MidMark Corp
7.7.1 MidMark Corp Details
7.7.2 MidMark Corp Major Business
7.7.3 MidMark Corp AI Diagnostics Product and Services
7.7.4 MidMark Corp AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 MidMark Corp Recent Developments/Updates
7.7.6 MidMark Corp Competitive Strengths & Weaknesses
7.8 Bio SB
7.8.1 Bio SB Details
7.8.2 Bio SB Major Business
7.8.3 Bio SB AI Diagnostics Product and Services
7.8.4 Bio SB AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Bio SB Recent Developments/Updates
7.8.6 Bio SB Competitive Strengths & Weaknesses
7.9 Cerora
7.9.1 Cerora Details
7.9.2 Cerora Major Business
7.9.3 Cerora AI Diagnostics Product and Services
7.9.4 Cerora AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Cerora Recent Developments/Updates
7.9.6 Cerora Competitive Strengths & Weaknesses
7.10 CellScope
7.10.1 CellScope Details
7.10.2 CellScope Major Business
7.10.3 CellScope AI Diagnostics Product and Services
7.10.4 CellScope AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 CellScope Recent Developments/Updates
7.10.6 CellScope Competitive Strengths & Weaknesses
7.11 Digital Diagnostics
7.11.1 Digital Diagnostics Details
7.11.2 Digital Diagnostics Major Business
7.11.3 Digital Diagnostics AI Diagnostics Product and Services
7.11.4 Digital Diagnostics AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Digital Diagnostics Recent Developments/Updates
7.11.6 Digital Diagnostics Competitive Strengths & Weaknesses
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Details
7.12.2 Siemens Healthineers Major Business
7.12.3 Siemens Healthineers AI Diagnostics Product and Services
7.12.4 Siemens Healthineers AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Siemens Healthineers Recent Developments/Updates
7.12.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.13 Nanox
7.13.1 Nanox Details
7.13.2 Nanox Major Business
7.13.3 Nanox AI Diagnostics Product and Services
7.13.4 Nanox AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Nanox Recent Developments/Updates
7.13.6 Nanox Competitive Strengths & Weaknesses
7.14 Roche
7.14.1 Roche Details
7.14.2 Roche Major Business
7.14.3 Roche AI Diagnostics Product and Services
7.14.4 Roche AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Roche Recent Developments/Updates
7.14.6 Roche Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 AI Diagnostics Industry Chain
8.2 AI Diagnostics Upstream Analysis
8.3 AI Diagnostics Midstream Analysis
8.4 AI Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World AI Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World AI Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World AI Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World AI Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World AI Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World AI Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World AI Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World AI Diagnostics Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key AI Diagnostics Players in 2023
Table 12. World AI Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global AI Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key AI Diagnostics Player
Table 15. AI Diagnostics Market: Company Product Type Footprint
Table 16. AI Diagnostics Market: Company Product Application Footprint
Table 17. AI Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China AI Diagnostics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China AI Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based AI Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Diagnostics Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies AI Diagnostics Revenue Market Share (2019-2024)
Table 23. China Based AI Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Diagnostics Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies AI Diagnostics Revenue Market Share (2019-2024)
Table 26. Rest of World Based AI Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI Diagnostics Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies AI Diagnostics Revenue Market Share (2019-2024)
Table 29. World AI Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World AI Diagnostics Market Size by Type (2019-2024) & (USD Million)
Table 31. World AI Diagnostics Market Size by Type (2025-2030) & (USD Million)
Table 32. World AI Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World AI Diagnostics Market Size by Application (2019-2024) & (USD Million)
Table 34. World AI Diagnostics Market Size by Application (2025-2030) & (USD Million)
Table 35. Oxitone Medical Ltd Basic Information, Area Served and Competitors
Table 36. Oxitone Medical Ltd Major Business
Table 37. Oxitone Medical Ltd AI Diagnostics Product and Services
Table 38. Oxitone Medical Ltd AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Oxitone Medical Ltd Recent Developments/Updates
Table 40. Oxitone Medical Ltd Competitive Strengths & Weaknesses
Table 41. MC10, Inc Basic Information, Area Served and Competitors
Table 42. MC10, Inc Major Business
Table 43. MC10, Inc AI Diagnostics Product and Services
Table 44. MC10, Inc AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. MC10, Inc Recent Developments/Updates
Table 46. MC10, Inc Competitive Strengths & Weaknesses
Table 47. Medtronic Basic Information, Area Served and Competitors
Table 48. Medtronic Major Business
Table 49. Medtronic AI Diagnostics Product and Services
Table 50. Medtronic AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Medtronic Recent Developments/Updates
Table 52. Medtronic Competitive Strengths & Weaknesses
Table 53. UE LifeSciences Basic Information, Area Served and Competitors
Table 54. UE LifeSciences Major Business
Table 55. UE LifeSciences AI Diagnostics Product and Services
Table 56. UE LifeSciences AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. UE LifeSciences Recent Developments/Updates
Table 58. UE LifeSciences Competitive Strengths & Weaknesses
Table 59. Vital Connect Basic Information, Area Served and Competitors
Table 60. Vital Connect Major Business
Table 61. Vital Connect AI Diagnostics Product and Services
Table 62. Vital Connect AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Vital Connect Recent Developments/Updates
Table 64. Vital Connect Competitive Strengths & Weaknesses
Table 65. Biomeme Basic Information, Area Served and Competitors
Table 66. Biomeme Major Business
Table 67. Biomeme AI Diagnostics Product and Services
Table 68. Biomeme AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Biomeme Recent Developments/Updates
Table 70. Biomeme Competitive Strengths & Weaknesses
Table 71. MidMark Corp Basic Information, Area Served and Competitors
Table 72. MidMark Corp Major Business
Table 73. MidMark Corp AI Diagnostics Product and Services
Table 74. MidMark Corp AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. MidMark Corp Recent Developments/Updates
Table 76. MidMark Corp Competitive Strengths & Weaknesses
Table 77. Bio SB Basic Information, Area Served and Competitors
Table 78. Bio SB Major Business
Table 79. Bio SB AI Diagnostics Product and Services
Table 80. Bio SB AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Bio SB Recent Developments/Updates
Table 82. Bio SB Competitive Strengths & Weaknesses
Table 83. Cerora Basic Information, Area Served and Competitors
Table 84. Cerora Major Business
Table 85. Cerora AI Diagnostics Product and Services
Table 86. Cerora AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Cerora Recent Developments/Updates
Table 88. Cerora Competitive Strengths & Weaknesses
Table 89. CellScope Basic Information, Area Served and Competitors
Table 90. CellScope Major Business
Table 91. CellScope AI Diagnostics Product and Services
Table 92. CellScope AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. CellScope Recent Developments/Updates
Table 94. CellScope Competitive Strengths & Weaknesses
Table 95. Digital Diagnostics Basic Information, Area Served and Competitors
Table 96. Digital Diagnostics Major Business
Table 97. Digital Diagnostics AI Diagnostics Product and Services
Table 98. Digital Diagnostics AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Digital Diagnostics Recent Developments/Updates
Table 100. Digital Diagnostics Competitive Strengths & Weaknesses
Table 101. Siemens Healthineers Basic Information, Area Served and Competitors
Table 102. Siemens Healthineers Major Business
Table 103. Siemens Healthineers AI Diagnostics Product and Services
Table 104. Siemens Healthineers AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Siemens Healthineers Recent Developments/Updates
Table 106. Siemens Healthineers Competitive Strengths & Weaknesses
Table 107. Nanox Basic Information, Area Served and Competitors
Table 108. Nanox Major Business
Table 109. Nanox AI Diagnostics Product and Services
Table 110. Nanox AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Nanox Recent Developments/Updates
Table 112. Roche Basic Information, Area Served and Competitors
Table 113. Roche Major Business
Table 114. Roche AI Diagnostics Product and Services
Table 115. Roche AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of AI Diagnostics Upstream (Raw Materials)
Table 117. AI Diagnostics Typical Customers
List of Figure
Figure 1. AI Diagnostics Picture
Figure 2. World AI Diagnostics Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World AI Diagnostics Total Market Size (2019-2030) & (USD Million)
Figure 4. World AI Diagnostics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World AI Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company AI Diagnostics Revenue (2019-2030) & (USD Million)
Figure 13. AI Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 16. World AI Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. United States AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 18. China AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. India AI Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of AI Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Diagnostics Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Diagnostics Markets in 2023
Figure 27. United States VS China: AI Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: AI Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World AI Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World AI Diagnostics Market Size Market Share by Type in 2023
Figure 31. Hardware
Figure 32. Software
Figure 33. Service
Figure 34. World AI Diagnostics Market Size Market Share by Type (2019-2030)
Figure 35. World AI Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World AI Diagnostics Market Size Market Share by Application in 2023
Figure 37. Hospitals
Figure 38. Research Laboratories
Figure 39. Contract Research Organizations
Figure 40. Others
Figure 41. AI Diagnostics Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche
jiaGou

Add To Cart

gouMai

Buy Now